{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:30:39Z","timestamp":1793050239380,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 847465"],"award-info":[{"award-number":["No 847465"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 847465"],"award-info":[{"award-number":["No 847465"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 847465"],"award-info":[{"award-number":["No 847465"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 847465"],"award-info":[{"award-number":["No 847465"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 847465"],"award-info":[{"award-number":["No 847465"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 847465"],"award-info":[{"award-number":["No 847465"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 847465"],"award-info":[{"award-number":["No 847465"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 847465"],"award-info":[{"award-number":["No 847465"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 847465"],"award-info":[{"award-number":["No 847465"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 847465"],"award-info":[{"award-number":["No 847465"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 847465"],"award-info":[{"award-number":["No 847465"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 847465"],"award-info":[{"award-number":["No 847465"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 847465"],"award-info":[{"award-number":["No 847465"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 847465"],"award-info":[{"award-number":["No 847465"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 847465"],"award-info":[{"award-number":["No 847465"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 847465"],"award-info":[{"award-number":["No 847465"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["No 847465"],"award-info":[{"award-number":["No 847465"]}]},{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11072-5","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T06:58:40Z","timestamp":1748415520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["DRTB-HDT: a randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis"],"prefix":"10.1186","volume":"25","author":[{"given":"Nestani","family":"Tukvadze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehlomola","family":"Mashatole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tlhago","family":"Ngwanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Van Rie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriu","family":"Crudu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tudor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Goginashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira","family":"Ibraim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso","family":"Khosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakira","family":"Rajaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinita","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Niemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Reither","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"11072_CR1","unstructured":"Global Tuberculosis Report 2024. 1st ed. World Health Organization; 2024."},{"issue":"3","key":"11072_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0954-6111(89)80031-9","volume":"83","author":"PA Willcox","year":"1989","unstructured":"Willcox PA, Ferguson AD. Chronic obstructive airways disease following treated pulmonary tuberculosis. Respir Med. 1989;83(3):195\u20138. https:\/\/doi.org\/10.1016\/S0954-6111(89)80031-9.","journal-title":"Respir Med"},{"key":"11072_CR3","doi-asserted-by":"crossref","unstructured":"High Morbidity during Treatment and Residual Pulmonary Disability in Pulmonary Tuberculosis: Under-Recognised Phenomena | PLOS One. https:\/\/journals.plos.org\/plosone\/article?id=https:\/\/doi.org\/10.1371\/journal.pone.0080302. Accessed 10 Mar 2025.","DOI":"10.1371\/journal.pone.0080302"},{"key":"11072_CR4","unstructured":"Residual lung damage after completion of treatment for multidrug-resistant tuberculosis - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/15182148\/. Accessed 10 Mar 2025."},{"key":"11072_CR5","doi-asserted-by":"crossref","unstructured":"A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung Disease | PLOS One. https:\/\/journals.plos.org\/plosone\/article?id=https:\/\/doi.org\/10.1371\/journal.pone.0161176. Accessed 10 Mar 2025.","DOI":"10.1371\/journal.pone.0161176"},{"issue":"5","key":"11072_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.rppneu.2011.06.010","volume":"17","author":"FC Di Naso","year":"2011","unstructured":"Di Naso FC, Pereira JS, Schuh SJ, Unis G. Avalia\u00e7\u00e3o funcional em pacientes com sequela pulmonar de tuberculose. Rev Port Pneumol. 2011;17(5):216\u201321. https:\/\/doi.org\/10.1016\/j.rppneu.2011.06.010.","journal-title":"Rev Port Pneumol"},{"issue":"3","key":"11072_CR7","doi-asserted-by":"publisher","first-page":"00026","DOI":"10.1183\/23120541.00026-2017","volume":"3","author":"AL Byrne","year":"2017","unstructured":"Byrne AL, Marais BJ, Mitnick CD, et al. Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis. ERJ Open Res. 2017;3(3):00026\u20132017. https:\/\/doi.org\/10.1183\/23120541.00026-2017.","journal-title":"ERJ Open Res"},{"issue":"5","key":"11072_CR8","doi-asserted-by":"publisher","first-page":"e613","DOI":"10.1016\/S2214-109X(19)30070-1","volume":"7","author":"M Duong","year":"2019","unstructured":"Duong M, Islam S, Rangarajan S, et al. Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort study. Lancet Glob Health. 2019;7(5):e613\u201323. https:\/\/doi.org\/10.1016\/S2214-109X(19)30070-1.","journal-title":"Lancet Glob Health"},{"key":"11072_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijcard.2017.02.012","volume":"234","author":"C Magnussen","year":"2017","unstructured":"Magnussen C, Ojeda FM, Rzayeva N, et al. FEV1 and FVC predict all-cause mortality independent of cardiac function \u2014 results from the population-based Gutenberg Health Study. Int J Cardiol. 2017;234:64\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2017.02.012.","journal-title":"Int J Cardiol"},{"issue":"10","key":"11072_CR10","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S1473-3099(19)30309-3","volume":"19","author":"K Romanowski","year":"2019","unstructured":"Romanowski K, Baumann B, Basham CA, Ahmad Khan F, Fox GJ, Johnston JC. Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2019;19(10):1129\u201337. https:\/\/doi.org\/10.1016\/S1473-3099(19)30309-3.","journal-title":"Lancet Infect Dis"},{"issue":"263","key":"11072_CR11","doi-asserted-by":"publisher","first-page":"263ra159","DOI":"10.1126\/scitranslmed.3009885","volume":"6","author":"A Singhal","year":"2014","unstructured":"Singhal A, Jie L, Kumar P, et al. Metformin as adjunct antituberculosis therapy. Sci Transl Med. 2014;6(263):263ra159. https:\/\/doi.org\/10.1126\/scitranslmed.3009885.","journal-title":"Sci Transl Med"},{"issue":"8","key":"11072_CR12","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41591-018-0087-6","volume":"24","author":"S Rangarajan","year":"2018","unstructured":"Rangarajan S, Bone NB, Zmijewska AA, et al. Metformin reverses established lung fibrosis in a bleomycin model. Nat Med. 2018;24(8):1121\u20137. https:\/\/doi.org\/10.1038\/s41591-018-0087-6.","journal-title":"Nat Med"},{"key":"11072_CR13","doi-asserted-by":"crossref","unstructured":"Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis | PLOS One. https:\/\/journals.plos.org\/plosone\/article?id=https:\/\/doi.org\/10.1371\/journal.pone.0187967. Accessed 10 Mar 2025.","DOI":"10.1371\/journal.pone.0187967"},{"key":"11072_CR14","doi-asserted-by":"crossref","unstructured":"Effect of glycemic control and type of diabetes treatment on unsuccessful TB treatment outcomes among people with TB-Diabetes: A systematic review | PLOS One. https:\/\/journals.plos.org\/plosone\/article?id=https:\/\/doi.org\/10.1371\/journal.pone.0186697. Accessed 10 Mar 2025.","DOI":"10.1371\/journal.pone.0186697"},{"issue":"3","key":"11072_CR15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bjid.2017.01.001","volume":"21","author":"S Marupuru","year":"2017","unstructured":"Marupuru S, Senapati P, Pathadka S, Miraj SS, Unnikrishnan MK, Manu MK. Protective effect of metformin against tuberculosis infections in diabetic patients: an observational study of south Indian tertiary healthcare facility. Braz J Infect Dis. 2017;21(3):312\u20136. https:\/\/doi.org\/10.1016\/j.bjid.2017.01.001.","journal-title":"Braz J Infect Dis"},{"issue":"6","key":"11072_CR16","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.chest.2017.11.040","volume":"153","author":"SW Pan","year":"2018","unstructured":"Pan SW, Yen YF, Kou YR, et al. The risk of TB in patients with type 2 diabetes initiating metformin vs sulfonylurea treatment. Chest. 2018;153(6):1347\u201357. https:\/\/doi.org\/10.1016\/j.chest.2017.11.040.","journal-title":"Chest"},{"key":"11072_CR17","unstructured":"Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/29943489\/. Accessed 10 Mar 2025."},{"key":"11072_CR18","unstructured":"Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/29325084\/. Accessed 10 Mar 2025."},{"key":"11072_CR19","unstructured":"Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/29679254\/. Accessed 10 Mar 2025."},{"key":"11072_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ebiom.2016.01.015","volume":"4","author":"S Subbian","year":"2016","unstructured":"Subbian S, Tsenova L, Holloway J, et al. Adjunctive phosphodiesterase-4 inhibitor therapy improves antibiotic response to pulmonary tuberculosis in a rabbit model. EBioMedicine. 2016;4:104\u201314. https:\/\/doi.org\/10.1016\/j.ebiom.2016.01.015.","journal-title":"EBioMedicine"},{"issue":"2","key":"11072_CR21","doi-asserted-by":"publisher","first-page":"e17091","DOI":"10.1371\/journal.pone.0017091","volume":"6","author":"MS Koo","year":"2011","unstructured":"Koo MS, Manca C, Yang G, et al. Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of mycobacterium tuberculosis in the lungs of infected mice. PLoS ONE. 2011;6(2):e17091. https:\/\/doi.org\/10.1371\/journal.pone.0017091.","journal-title":"PLoS ONE"},{"issue":"8","key":"11072_CR22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S2213-2600(20)30448-3","volume":"9","author":"RS Wallis","year":"2021","unstructured":"Wallis RS, Ginindza S, Beattie T, et al. Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial. Lancet Respir Med. 2021;9(8):897\u2013908. https:\/\/doi.org\/10.1016\/S2213-2600(20)30448-3.","journal-title":"Lancet Respir Med"},{"key":"11072_CR23","unstructured":"World Health Organization. WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment. World Health Organization; 2019. https:\/\/iris.who.int\/handle\/10665\/311389. Accessed 10 Mar 2025."},{"issue":"RR-4","key":"11072_CR24","first-page":"207","volume":"58","author":"JE Kaplan","year":"2009","unstructured":"Kaplan JE, Benson C, Holmes KK, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV medicine association of the infectious diseases society of America. MMWR Recomm Rep. 2009;58(RR-4):207 (quiz CE1-4).","journal-title":"MMWR Recomm Rep"},{"key":"11072_CR25","unstructured":"A simple sample size formula for analysis of covariance in randomized clinical trials - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/17998077\/. Accessed 10 Mar 2025."},{"key":"11072_CR26","unstructured":"E 9 Statistical Principles for Clinical Trials. Published online 2006."},{"key":"11072_CR27","unstructured":"Multiple Endpoints in Clinical Trials Guidance for Industry."},{"key":"11072_CR28","unstructured":"Draft-guideline-multiplicity-issues-clinical-trials_en.pdf. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-multiplicity-issues-clinical-trials_en.pdf. Accessed 10 Mar 2025."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11072-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11072-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11072-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T06:58:44Z","timestamp":1748415524000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11072-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11072"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11072-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol, the informed consent forms, and investigator brochures were submitted and approved by all relevant ethics committees listed in Table\u00a0\n                      \n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"All authors consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"768"}}